Home » Prices » NASDAQ:JNCE

Jounce Therapeutics, Inc. NASDAQ:JNCE

Today's live share price, quote history, chart & news

Price:
7.96 USD
Change:
-0.77 (-8.82%)
Key Stats
Price open 8.67
Previous close 8.73
Market cap 272.35M
Volume 733.06K
Day high 8.882
Day low 7.93
Year high 11.72
Year low 2.79
Year to date change -8.48%
P/E Ratio 11.27
Company Profile
Fundamentals
Insider Information
News

About Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which treat cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients. Its products pipeline include JTX-2011 (ICOS); JTX-4014 (PD-1); Lead Macrophage Program; Macrophage Targeting; T Reg; B Cells; and Stromal Targeting. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA.

Company information

Company name
Jounce Therapeutics, Inc.
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
130
CEO
Richard Murray
Address
780 Memorial Drive, Cambridge, MA, 02139
Country
United States
Contact information
1.857.259.3840
Website
http://www.jouncetx.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.